Current Neuropharmacology

Editor-in-Chief:

T.E. Salt
University College London
Institute of Ophthalmology
London EC1V 9EL
UK

Back

Ahead of Print Article(s)

Experimental Drugs for Neuropathic Pain

Volume:16
Kinga Salat*, Beata Gryzlo and Katarzyna Kulig

Glaucoma Pathogenesis and Neurotrophins: Focus on the Molecular and Genetic Basis for Therapeutic Prospects

Volume:16
Nitin Chitranshi*, Yogita Dheer, Mojdeh Abbasi, Yuyi You, Stuart L Graham and Vivek Gupta

Closed-loop Neuropharmacology for Epilepsy: Distant Dream or Future Reality?

Volume:16
Irene Aicua-Rapun*, Pascal Andre and Jan Novy

Antioxidant Properties of Crocus Sativus L. and Its Constituents and Relevance to Neurodegenerative Diseases; Focus on Alzheimer’s and Parkinson’s Disease

Volume:16
Kyriaki Hatziagapiou*, Eleni Kakouri, George I. Lambrou*, Kostas Bethanis and Petros A. Tarantilis

Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options

Volume:16
Emine Sekerdag*, Ihsan Solaroglu and Yasemin Gursoy-Ozdemir

Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer’s Disease: A Systematic Review

Volume:16
Ianara Mendonca Costa, Marco Aurelio de Moura Freire, Jose Rodolfo Lopes de Paiva Cavalcanti, Dayane Pessoa Araujo, Bianca Norrara, Isleania Maria Marques Moreira Rosa, Eduardo Pereira de Azevedo, Amalia Cinthia Meneses Rego, Irami Araujo-Filho and Fausto Pierdona Guzen*

Pharmacological Treatment of Body Dysmorphic Disorder

Volume:16
Kevin Hong, Vera Nezgovorova, Genoveva Uzunova, Danya Schlussel and Eric Hollander*

Nerve Growth Factor: Early Studies and Recent Clinical Trials

Volume:16
Maria Luisa Rocco, Marzia Soligo, Luigi Manni and Luigi Aloe*

In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease

Volume:16
Agostinho Lemos, Rita Meloc, Antonio J. Preto, Jose G. Almeida, Irina S. Moreira and M. Natalia D. S. Cordeiro*

Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Designing

Volume:16
Sheikh Arslan Sehgal*, Mirza A. Hammad, Rana Adnan Tahir, Hafiza Nisha Akram and Faheem Ahmad

The Delicate Equilibrium between Oxidants and Antioxidants in Brain Glioma

Volume:16
Maria Jesus Ramirez-Exposito and Jose Manuel Martinez-Martos*

Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw

Volume:16
Shilpa Sharma and Ravi Shankar Akundi*

The Role of LRRK2 in Neurodegeneration of Parkinson Disease

Volume:16
Qin Rui, Haibo Ni, Di Li*, Rong Gao* and Gang Chen

Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness

Volume:16
Jonathan Hamill, Jaime Hallak, Serdar M. Dursun and Glen Baker*

Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities

Volume:16
Amalia Merelli, Julio Cesar Garcia Rodriguez, Jaume Folch, Marcelo R. Regueiro, Antoni Camins and Alberto Lazarowski*

Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease

Volume:15
Hui Li , Xiaobing Wang, Hongmei Yu, Jing Zhu, Hongtao Jin, Aiping Wang and Zhaogang Yang*

Neurostimulation in Clinical and Sub-clinical Eating Disorders: A Systematic Update of the Literature

Volume:16
Bethan Dalton, Savani Bartholdy, Iain C Campbell and Ulrike Schmidt*

Computer-aided Drug Design Applied to Parkinson Targets

Volume:15
Hamilton M. Ishiki, Jose Maria Barbosa Filho, Marcelo S. da Silva, Marcus T. Scotti and Luciana Scotti*

Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review

Volume:16
Simone Pisano*, Marco Pozzi, Gennaro Catone, Giulia Scrinzi , Emilio Clementi, Giangennaro Coppola, Annarita Milone, Carmela Bravaccio, Paramala Santosh and Gabriele Masi

Autophagy after Subarachnoid Hemorrhage: Can Cell Death be Good?

Volume:15
Wing-Mann Ho*, Onat Akyol, Haley Reis, Cesar Reis, Devin McBride, Claudius Thome and John Zhang

Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights

Volume:15
Soumen Khatua*, Anne Song, Divyaswathi Citla Sridhar and Stephen C. Mack

Targeting Cytokines for Morphine Tolerance: A Narrative Review

Volume:15
Dai-Qiang Liu, Ya-Qun Zhou and Feng Gao*

Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge

Volume:15
Riccardo Zanni, Ramon Garcia-Domenech, Maria Galvez-Llompart and Jorge Galvez*

Oxytocin and Eating Disorders: A Narrative Review on Emerging Findings and Perspectives

Volume:15
Katrin Giel*, Stephan Zipfel and Manfred Hallschmid

Neural Network Alterations Across Eating Disorders: A Narrative Review of fMRI Studies

Volume:15
Trevor Steward, José M. Menchón, Susana Jiménez-Murcia, Carles Soriano-Mas and Fernando Fernández-Aranda*

Extend, Pathomechanism and Clinical Consequences of Brain Volume Changes in Anorexia Nervosa

Volume:15
Jochen Seitz*, Kerstin Konrad and Beate Herpertz-Dahlmann

Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain

Volume:16
Raffaele Mancino, Alessio Martucci, Massimo Cesareo, Clarissa Giannini , Maria Tiziana Corasaniti , Giacinto Bagetta and Carlo Nucci *

Rational Basis for Nutraceuticals in the Treatment of Glaucoma

Volume:15
Luigi Antonio Morrone *, Laura Rombola , Annagrazia Adornetto , Tiziana Maria Corasaniti and Rossella Russo

Noninvasive Cerebellar Stimulation as a Complement Tool to Pharmacotherapy

Volume:15
Roberta Ferrucci*, Tommaso Bocci, Francesca Cortese, Fabiana Ruggiero and Alberto Priori

Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy

Volume:15
Upasana Ganguly*, Sankha Shubhra Chakrabarti*, Upinder Kaur, Anwesha Mukherjee and Sasanka Chakrabarti

Blood Brain Barrier and Alzheimer’s Disease: Similarity and Dissimilarity of Molecular Alerts

Volume:15
Alla P. Toropova*, Andrey A. Toropov, S. Begum and P. G. R. Achary

Impact of Dietary Fats on Brain Functions

Volume:15
Rosanna Chianese, Roberto Coccurello, Andrea Viggiano, Marika Scafuro, Marco Fiore, Giangennaro Coppola, Francesca Felicia Operto, Silvia Fasano, Sophie Layé, Riccardo Pierantoni and Rosaria Meccariello*

Relevance of CYP2C9 Function in Valproate Therapy

Volume:15
Katalin Monostory*, Andrea Nagy, Katalin Toth, Tamas Budi, Adam Kiss, Mate Deri and Gabor Csukly

Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias

Volume:15
Emanuele Barca*, Valentina Emmanuele, Salvatore DiMauro, Antonio Toscano and Catarina M. Quinzii

The Role of CXCR3 in Neurological Diseases

Volume:15
Ya-Qun Zhou, Dai-Qiang Liu, Shu-Ping Chen, Jia Sun, Xue-Rong Zhou, Cui Xing , Da-Wei Ye* and Yu-Ke Tian

In Silico Studies in Drug Research Against Neurodegenerative Diseases

Volume:15
Farahnaz Rezaei Makhouri and Jahan B. Ghasemi*

Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms

Volume:15
Lang-Yue Hu, Wen-Li Mi, Gen-Cheng Wu, Yan-Qing Wang and Qi-Liang Mao-Ying*

Computer Aided Drug Design and its Application to the Development of Potential Drugs for Neurodegenerative Disorders

Volume:15
Mohammad Hassan Baig*, Khurshid Ahmad, Gulam Rabbani, Danishuddin and Inho Choi*

NGF and BDNF Alterations by Prenatal Alcohol Exposure

Volume:15
Valentina Carito, Mauro Ceccanti, Giampiero Ferraguti, Roberto Coccurello, Stefania Ciafrè, Paola Tirassa and Marco Fiore*

QSAR Modeling of Histamine H3R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases

Volume:15
Michelle Fidelis Corrêa and João Paulo dos Santos Fernandes*

Current Perspectives for the use of Gonane Progesteronergic Drugs in the Treatment of Central Hypoventilation Syndromes

Volume:15
Camille Loiseau, Florence Cayetanot, Fanny Joubert, Anne-Sophie Perrin-Terrin, Philippe Cardot, Marie-Noëlle Fiamma, Alain Frugiere, Christian Straus and Laurence Bodineau*

Novel Therapeutics in Glaucoma Management

Volume:15
Claudio Bucolo*, Chiara Bianca Maria Platania, Filippo Drago, Michele Reibaldi, Vincenza Bonfiglio, Teresio Avitabile and Maurizio Uva

Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases

Volume:15
Cinzia Rapino*, Daniel Tortolani, Lucia Scipioni and Mauro Maccarrone*

Modulation of the Immune System for the Treatment of Glaucoma

Volume:15
Katharina Bell, Nadine von Thun und Hohenstein-Blaul, Julia Teister and Franz H. Grus*

Neuroprotective Role of Agmatine in Neurological Diseases

Volume:15
Weilin Xu, Liansheng Gao, Tao Li, Anwen Shao* and Jianmin Zhang*

Recent Advances in Pathophysiology of Traumatic Brain Injury

Volume:15
Parmeet Kaur and Saurabh Sharma*

Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy

Volume:15
Rosario Amato, Massimo Dal Monte, Matteo Lulli, Vittoria Raffa and Giovanni Casini*

Statins and the Brain: More than Lipid Lowering Agents

Volume:15
Anna Fracassi , Martina Marangoni, Pamela Rosso, Valentina Pallottini, Marco Fioramonti, Silvia Siteni and Marco Segatto*

Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases

Volume:15
Jose M. Vega-Riquer , Gerardo Mendez-Victoriano , Raul A. Morales-Luckie and Oscar Gonzalez-Perez *

Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?

Volume:15
Caroline Victorri-Vigneau*, Andrew Spiers , Pascal Caillet, Mélanie Bruneau , IGNACE-consortium, Gaëlle Challet-Bouju and Marie Grall-Bronnec

Strategies to Reduce Oxidative Stress in Glaucoma Patients

Volume:15
M D Pinazo-Durán *, K Shoaie-Nia, V Zanón-Moreno, SM Sanz-González , Benítez del Castillo J and JJ García-Medina

Experimental Models for Aging and their Potential for Novel Drug Discovery

Volume:15
Jaume Folch , Oriol Busquets , Miren EttchetoElena Sánchez-López, Mercè Pallàs, Carlos Beas-Zarate, Miguel Marin, Gemma Casadesus, Jordi Olloquequi, Carme Auladell and Antoni Camins *

Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects

Volume:15
Spyridon Siafis , Dimitrios Tzachanis , Myrto Samara and Georgios Papazisis *

Programmed Cell Death after Intracerebral Hemorrhage

Volume:15
Tobias Bobinger, Petra Burkardt, Hagen B. Huttner and Anatol Manaenko

Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function

Volume:15
Vincenzo Parisi, Francesco Oddone*, Lucia Ziccardi, Gloria Roberti, Gianluca Coppola and Gianluca Manni

Role of Ectonucleotidases in the Synapse Formation During Brain Development: Physiological and Pathological Implications

Volume:15
Ivana Grković*, Dunja Drakulić, Jelena Martinović and Nataša Mitrović

The Role of Autophagy in Subarachnoid Hemorrhage: An Update

Volume:15
Yuanjian Fang, Sheng Chen, Cesar Reis and Jianmin Zhang *

Levodopa in Parkinson’s Disease: Current Status and Future Developments

Volume:15
N. Tambasco*, M. Romoli and P. Calabresi